Off-label promotion, on-target sales

Adriane Fugh-Berman and Douglas Melnick describe techniques by which pharmaceutical companies covertly promote off-label drug use even where such promotion is illegal.

Saved in:
Bibliographic Details
Published in:PLoS medicine 2008-10, Vol.5 (10), p.e210-e210
Main Authors: Fugh-Berman, Adriane, Melnick, Douglas
Format: Article
Language:English
Subjects:
Abortion
Cancer therapies
Clinical trials
Consumer protection
Drug Industry - methods
Drug Industry - standards
Drug Labeling - methods
Drug Labeling - standards
Drug Prescriptions - standards
Drug use
Drug Utilization - standards
Drugs and adverse drug reactions
Ethics
Evidence-Based Healthcare
FDA approval
Funding
Humans
Macular degeneration
Marketing
Medical education
Medical journals
Non-Clinical Medicine
Obstetrics
Pharmaceutical industry
Policy Forum
Pregnancy
Prescription drugs
Public Health
Public Health and Epidemiology
Rabies
Rare diseases
Regulation
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Adriane Fugh-Berman and Douglas Melnick describe techniques by which pharmaceutical companies covertly promote off-label drug use even where such promotion is illegal.
ISSN:1549-1676
1549-1277
1549-1676
DOI:10.1371/journal.pmed.0050210